Skip to main content
SpringerLink
Log in

Hypochondriasis needs to be taken seriously to achieve the best outcome

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Magarinos M, Zafar U, Nissenson K, et al. Epidemiology and treatment of hypochondriasis. CNS Drugs 2002; 16(1): 9–22

    Article  PubMed  Google Scholar 

  2. Gureje O, Ustun TB, Simon GE. The syndrome of hypochondriasis: a cross-national study in primary care. Psychol Med 1997; 27: 1001–10

    Article  PubMed  CAS  Google Scholar 

  3. Noyes R. Epidemiology of hypochondriasis. In: Storcevic V, Lipsitt DR, editors. Hypochondriasis: modern perspectives on an ancient malady. New York: Oxford University Press, 2001: 127–54

    Google Scholar 

  4. Noyes R, Holt CS, Happel RL, et al. A family study of hypochondriasis. J Nerv Ment Dis 1997; 185: 223–32

    Article  PubMed  Google Scholar 

  5. Barsky AJ, Wool C, Barnett MC, et al. Histories of childhood trauma in adult hypochondriacal patients. Am J Psychiatry 1994; 151: 397–401

    PubMed  CAS  Google Scholar 

  6. Barsky AJ, Fama JM, Bailey ED, et al. A prospective four-five year study of DSM-III-R hypochondriasis. Arch Gen Psychiatry 1998; 55: 737–44

    Article  PubMed  CAS  Google Scholar 

  7. Barsky AJ. The patient with hypochondriasis. N Engl J Med 2001 Nov 8; 345(19): 1395–9

    Article  PubMed  CAS  Google Scholar 

  8. Clark DM, Salkovskis PM, Hackmann A, et al. Two psychological treatments for hypochondriasis: a randomised controlled trial. Br J Psychiatry 1998; 173: 218–25

    Article  PubMed  CAS  Google Scholar 

  9. Visser S, Bouman TK. Cognitive-behavioral approaches in the treatment of hypochondriasis: six single case cross-over studies. Behav Res Ther 1992; 30: 301–6

    Article  PubMed  CAS  Google Scholar 

  10. Avia MD, Ruiz MA, Olivares ME, et al. The meaning of psychological symptoms: effectiveness of a group intervention with hypochondriacal patients. Behav Res Ther 1996; 34: 23–31

    Article  PubMed  CAS  Google Scholar 

  11. Fallon BA, Javitch JA, Hollander E, et al. Hypochondriasis and obsessive-compulsive disorder: overlaps in diagnosis and treatment. J Clin Psychiatry 1991; 52: 457–60

    PubMed  CAS  Google Scholar 

  12. Bodkin JA, White K. Clonazepam in the treatment of obsessive compulsive disorder associated with panic disorder in one patient. J Clin Psychiatry 1989; 50: 265–6

    PubMed  CAS  Google Scholar 

  13. Viswanathan R, Paradis C. Treatment of cancer phobia with fluoxetine [abstract]. Am J Psychiatry 1991; 148: 1090

    PubMed  CAS  Google Scholar 

  14. Fallon BA, Qureshi AI, Laje G, et al. Hypochondriasis and its relationship with obsessive-compulsive disorder. Psychiatr Clin North Am 2000; 23: 605–16

    Article  PubMed  CAS  Google Scholar 

  15. Fallon BA, Schneier FR, Marshall R, et al. The pharmacotherapy of hypochondriasis. Psychopharmacol Bull 1996; 32(4): 607–11

    PubMed  CAS  Google Scholar 

  16. Fallon BA, Liebowitz MR, Salman E, et al. Fluoxetine for hypochondriacal patients without major depression. J Clin Psychopharmacol 1993; 13: 438–41

    Article  PubMed  CAS  Google Scholar 

  17. Wesner RB, Noyes R. Imipramine: an effective treatment for illness phobia. J Affect Disord 1991; 22: 43–8

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hypochondriasis needs to be taken seriously to achieve the best outcome. Drugs Ther. Perspect 18, 6–9 (2002). https://doi.org/10.2165/00042310-200218110-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200218110-00003

Keywords

Search

Navigation